Synchronous BRCA2 positive ovarian carcinoma with ALK positive NSCLC: Double trouble
Lung cancer being a molecularly distinct entity in the female population, multiple primary tumors including the genital and urinary tract malignancies with lung carcinoma is rare and constitutes a unique set of patient population. This case report serves to illustrate the rarity of multiple primary...
Saved in:
Main Authors: | Ullas Batra (Author), Shrinidhi Nathany (Author), Mansi Sharma (Author), Anila Sharma (Author), Sunil Pasricha (Author), Vidya Menon (Author), Joslia T. Jose (Author), Anurag Mehta (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discordant EGFR mutation results: A case report
by: Ullas Batra, et al.
Published: (2022) -
ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
by: Uruga H, et al.
Published: (2018) -
ALK positive histiocytosis in an adult female with an EML4-ALK RNA fusion
by: Jay Mehta, et al.
Published: (2020) -
Extradural spinal melanoma: is it primary or metastatic? A case report with a brief review of literature
by: Raghav Kapoor, et al.
Published: (2024) -
Therapeutic Sequencing in ALK<sup>+</sup> NSCLC
by: Mei Elsayed, et al.
Published: (2021)